Analyst Ratings for CRISPR Therapeutics (CRSP)

CRSP Rating Summary

CRSP Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CRSP
Overall Rating: BUY   Rating Trend: Down   Avg. $ Target: $149.93 (+44.8%) * Over Last 12-Mos
Rating Score: 6.2 / 10   Percentile Rank: 65%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
4/21/2021 Jefferies Maury Raycroft Upgrade Buy
(Hold)
N/A
(N/A)
121.67
(103.54)
-14.9% Details
3/4/2021 JMP Securities Silvan Tuerkcan New Coverage Market Outperform
(N/A)
160.00
(N/A)
129.77
(103.54)
-20.21% Details
Like CRSP Ratings? Also take a look at VRTX, NKTX, NTLA, EDIT

CRSP Ratings News